GIEQ - ETF AI Analysis
Top Page
Goldman Sachs Data Enhanced International Equity ETF (GIEQ)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Lead Holding
The largest position, ASML Holding, has shown very strong gains this year, giving the fund a helpful performance boost.
Broad Country Diversification
Holdings spread across many developed markets like Japan, the UK, France, Germany, and others help reduce the impact of problems in any single country.
Moderate Expense Ratio
The fund’s fee is reasonably low for an actively managed international strategy, allowing investors to keep more of their returns.
Negative Factors
Mixed Top-Holding Performance
Several major holdings such as Nestlé, Roche, and AstraZeneca have been weak this year, which can drag on overall returns.
Heavy Japan and Europe Exposure
A large share of assets in Japan and major European markets means the fund is sensitive to economic or political issues in those regions.
Small Asset Base
With relatively low assets under management, the ETF may face higher trading spreads and a greater risk of closure compared with larger funds.
GIEQ vs. SPDR S&P 500 ETF (SPY)
AUM10.46M
RegionGlobal Ex-U.S.
Expense Ratio0.30%
Beta0.90
IssuerGoldman Sachs
Inception DateMay 19, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume179
30 Day Avg. Volume211
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
45.61Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering250
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GIEQ Summary
GIEQ is the Goldman Sachs Data Enhanced International Equity ETF, an actively managed fund that invests in a wide mix of companies outside the U.S., across both developed and emerging markets. It uses data and research to pick stocks from many countries like Japan, the UK, and France, and across many sectors. Well-known holdings include ASML and Nestlé. An investor might choose this ETF to diversify beyond U.S. stocks and seek long-term global growth in a single fund. Risk: the value can go up and down with international stock markets and currency moves.
How much will it cost me?This ETF has an expense ratio of 0.30%, which means you’ll pay about $3.00 per year for every $1,000 invested. That cost is a bit higher than many low-cost index ETFs because this fund is actively managed using Goldman Sachs’ data-driven and research-based approach.
What would affect this ETF?This ETF could benefit if global growth outside the U.S. stays healthy, especially for large international technology, health care, and industrial companies like ASML, AstraZeneca, and Siemens, and if stable or falling interest rates support financial firms such as Allianz, UBS, and Mitsubishi UFJ. On the negative side, it may be hurt by slowdowns in Europe or Asia, rising global interest rates that pressure banks and borrowers, stronger U.S. dollar moves that reduce foreign stock returns for U.S. investors, or new regulations and political tensions affecting major markets and sectors like financials, materials, and energy.
GIEQ Top 10 Holdings
GIEQ leans heavily on a handful of non-U.S. heavyweights, with chip-equipment star ASML doing much of the lifting as its strong run powers the fund’s tech exposure. Cyclical names like BHP and industrial leader Siemens are also rising, giving the portfolio a tailwind from materials and industrials. On the flip side, defensive giants Nestlé, Roche, and AstraZeneca have been lagging, acting more like ballast than boosters. Financials such as Allianz, Mitsubishi UFJ, and UBS sit in the middle, generally steady to rising, underscoring the fund’s diversified, global ex-U.S. stance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.67% | $382.33K | €619.66B | 138.67% | 76 Outperform | |
| Nestlé SA | 1.65% | $171.75K | CHF203.49B | -2.60% | 71 Outperform | |
| Roche Holding AG | 1.42% | $147.45K | $328.05B | 25.86% | 73 Outperform | |
| BHP Group Ltd | 1.40% | $145.70K | AU$331.16B | 91.21% | 68 Neutral | |
| AstraZeneca | 1.32% | $138.06K | $274.84B | 24.59% | 80 Outperform | |
| Allianz | 1.30% | $135.70K | €149.47B | 16.53% | 67 Neutral | |
| Siemens | 1.28% | $133.43K | €206.08B | 27.95% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 1.26% | $130.81K | ¥36.25T | 54.17% | 76 Outperform | |
| UBS Group AG | 1.24% | $128.81K | $150.96B | 59.78% | 73 Outperform | |
| SAFRAN SA | 1.17% | $122.23K | €131.91B | 26.44% | 67 Neutral |
GIEQ Technical Analysis
Positive
―
Price Trends
Market Momentum
58.05
Neutral
94.48
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GIEQ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at 58.05 is Neutral, neither overbought nor oversold. The STOCH value of 94.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GIEQ.
GIEQ Peer Comparison
Comparison Results
Performance Comparison
GIEQ
Goldman Sachs Data Enhanced International Equity ETF
41.62
0.89
2.19%
AADR
AdvisorShares Dorsey Wright ADR ETF
―
―
―
ESIM
Eventide International ETF
―
―
―
VNIE
Vontobel International Equity Active ETF
―
―
―
PGRI
Putnam International Stock ETF
―
―
―
TINS
Templeton International Insights ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents